CRISPR NEWS

UK: Patents granted to Doudna-Charpentier

The United Kingdom’s Intellectual Property Office awarded two patents to the Doudna-Charpentier team, with the first UK patent covering the single-guide RNA format of the CRISPR-Cas9 system and its use in any environment (including plant, animal and human cells). This patent also includes claims covering the use of CRISPR-Cas9 in producing medicines for treating disease. A second UK patent focuses on modified Cas9 that incorporates additional DNA-modulating functions such as the regulation of gene expression.

 

LATEST

Sign up to receive updates from the CRISPR Collective

Related News

U.S. Patent and Trademark Office issues 9th and 10th CRISPR patents to CVC July 23, 2019
U.S. Patent and Trademark Office issues 8th CRISPR patent to CVC July 16, 2019
U.S. Patent and Trademark Office issues 7th CRISPR patent to CVC July 2, 2019
Read moreArrow-down